Medicines

Combating Counterfeit Drugs: Building Effective International Collaboration, 16-18 February 2006 - Rome, Italy

The World Health Organization (WHO) is organizing the conference 'Combating Counterfeit Drugs: Building Effective International Collaboration', to be held from 16 to 18 February 2006 in Rome, Italy.

Background

Regulatory authorities of more than 60 countries and other concerned parties gathered in Madrid from 13 to 14 February 2004 for a two-day Satellite Conference on Counterfeit Medicines organized by WHO in conjunction with the Eleventh International Conference of Drug Regulatory Authorities (11th ICDRA). This pre-ICDRA conference discussed strategies and international collaboration aimed at combating counterfeit pharmaceutical products.

Objectives

The pre-ICDRA conference 2004 requested WHO to convene, prior to the 12th ICDRA, a meeting with drug regulatory authorities and other stakeholders to specifically consider a concept paper proposing a draft convention on counterfeit drugs.

The objectives of the meeting to be held in Rome next February are as follows:

  • to recommend concrete action in view of building effective international collaboration on combating counterfeit drugs,
  • to recommend concrete initiatives in view of establishing a mechanism for concerted international action against counterfeit medicinal products.

The conference is organized by WHO and supported by the Italian Medicines Agency (AIFA), and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA).

WHO invites all its Member States to actively participate in this event and meet with a number of International organizations and associations such as the European Commission, Council of Europe, Organisation for Economic Co-operation and Development, World Trade Organization, World Intellectual Property Organization, World Medical Association, World Bank, International Pharmaceutical Federation (FIP), International Council of Nurses, World Customs Organization, Interpol, International Federation of Pharmaceutical Manufacturers Associations, International Generic Pharmaceutical Alliance, World Self-Medication Industry, European Association of Pharmaceutical Wholesalers, International Federation of Pharmaceutical Wholesalers, Pharmaceutical Security Institute, International Alliance of Patients' Organizations, Consumers International, Pharmaciens sans Frontières, German Pharma Health Fund, Safe Medicines Alliance.

Participation

Please note that, for practical reasons, we need to limit the number of participants. Participation in the Conference is therefore by invitation only. Invitations have been sent to governments of all WHO Member States and to international and non-governmental organizations (see above). If an invitation has not been addressed to you it may have reached your government or your organization. Invited organizations decide who shall represent them at the Conference. However, we may have missed organizations who have made important contributions on this topic and we are ready to extend the list of invitees.
If you feel that none of the organizations mentioned here above can satisfactorily represent your views and proposals, please write to us: counterfeitconf@who.int, explaining why you are not satisfied and providing some background to justify your participation. We shall be pleased to consider your suggestions.

The conference web site and addtitional resources available:

Contact

For further information, please contact: counterfeitconf@who.int

Share

“counterfeit medicines are a threat to our communities and must be stopped ”